Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

Avastin pack shot

FDA’s rejection of Avastin creates conflict

October 31, 2011 Research and Development, Sales and Marketing FDA, avastin, breast cancer

Oncology experts have expressed concern at the FDA’s rejection of Roche’s Avastin for the treatment of advanced breast cancer. A …
News
peter_maag

Carsten Schroeder appointed interim president of Novartis Diagnostics

October 31, 2011 Sales and Marketing Novartis

Schroeder was previously vice president of Novartis Diagnostics for commercial operations in Europe, the Middle East and Africa. He will …
Appointment
Swiss protest image

Novartis job cuts protest

October 31, 2011 Manufacturing and Production, Sales and Marketing Novartis, job cuts, manufacturing and production

Protesters have been demonstrating outside the home of Novartis chairman Daniel Vasella and in the streets of Basel, Switzerland, in …
News

Core products boost Merck’s results

October 31, 2011 Medical Communications, Sales and Marketing Gardasil, Merck, Victrelis

Sales of core products and favourable exchange rates have helped Merck grow its revenue in a tough environment.  Worldwide sales …
News

Brilique gains NICE approval

October 31, 2011 Sales and Marketing ACS, Brilique, NICE, Plavix, clopidogrel

AstraZeneca’s Brilique has been approved by NICE for use in combination with aspirin as an option to treat patients with …
News

Boehringer agrees Pradaxa kidney function warning

October 30, 2011 Sales and Marketing AF, EMA, Pradaxa, renal function

Boehringer Ingelheim is to alert doctors in Europe of the need to check patients’ kidney function before prescribing anticoagulant Pradaxa. …
News

Emerging markets help Bayer through tough quarter

October 28, 2011 Sales and Marketing Bayer, Xarelto, emerging markets

Bayer has posted modest results for the third quarter, with growth in emerging markets compensating for austerity measures in Europe …
News

AstraZeneca weathers patent expiry storm

October 27, 2011 Sales and Marketing AstraZeneca, AstraZenecca, q3 2011

 AstraZeneca saw its revenue decline in the third quarter due to an onslaught of patent expiries, but still saw its …
News

Biogen’s MS drug hits phase III targets

October 27, 2011 Sales and Marketing BG-12, Biogen, MS

Biogen’s potential blockbuster MS drug BG-12 has met its primary endpoint in a late-stage trial.   BG-12 (dimethyl fumarate) tablets …
News
GSK logo

GSK sees strong Q3 after battling headwinds

October 27, 2011 Business Services, Sales and Marketing GSK, GSK. Q3, Q3

GlaxoSmithKline has posted a set of healthy figures for the third quarter, underlying its return to growth after a tough …
News
NICE building

Mepact wins NICE backing

October 26, 2011 Research and Development, Sales and Marketing Mepact, NICE

NICE has recommended Takeda’s bone cancer drug Mepact after the firm offered a discount for the treatment. The watchdog’s final …
News

Reforms raise conflicts of interest, say GPs

October 25, 2011 Sales and Marketing BMA, NHS, NHS reforms

Two-thirds of doctors believe that the government’s health reforms will create conflicts of interests in their jobs and undermine their …
News

David Meeker appointed as chief executive of Genzyme

October 25, 2011 Research and Development, Sales and Marketing Genzyme, Sanofi

Sanofi has appointed David Meeker as chief executive of its new biotech acquisition Genzyme. He will report to Christopher Viehbacher, …
Appointment
Sanofi HQ

Sanofi’s Lemtrada beats Rebif in MS study

October 25, 2011 Research and Development, Sales and Marketing Lemtrada, Sanofi

Sanofi’s investigational multiple sclerosis drug Lemtrada has beaten Rebif in a late-stage trial. The Phase III results show that 78% …
News

Risk Based Inspections for good pharmacovigilance practice

October 24, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Recently in the UK there has been a move towards risk-based inspection programmes.  The scope, frequency and depth of MHRA …
News
Press release
The Gateway to Local Adoption Series

Latest content

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026